feels weak; sore throat; general malaise; chills; fever; severe headache; cough; extreme fatigue; pain coming up the neck; being down for 14 weeks/ miserable; Based on additional information on 03-Mar-2017, this case became medical confirmed due to addition of the reporter physician.     Initial information regarding an unsolicited valid non-serious case from a consumer/ non-health care professional via Medical Information (Reference number- 00481715).  This case involves a 66-year old female patient who experienced general malaise (malaise), chills, fever (pyrexia), severe headache (headache), cough, sore throat (oropharyngeal pain), felt weak (asthenia), pain coming up the neck (neck pain), being down for 14 weeks/ miserable (depressed mood) and extreme fatigue (fatigue), while patient received INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] and SPLIT TRITON INTRADERMAL THIOMERSAL FREE VACCINE [IDFLU].  Medical history included Multiple allergies and Hypothyroidism.  Past medical treatment(s), vaccination(s) and family history were not provided.  At the time of the event, the patient had ongoing Drug hypersensitivity [Allergic to general anesthesia, allergy to levuqwn, allergic to nonsteroidal anti-inflammatory drugs, allergic to tetanus toxoid absorbed].  Concomitant medications included LEVOTHYROXINE SODIUM (SYNTHROID) and COLECALCIFEROL (VITAMIN D3).   On 19-Sep-2016 at 10:03, the patient received a dose of 0.5 ml Total (once) suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (lot number: UI620AB, V1620AB and expiration date: unknown) via unknown route in the right deltoid for prophylactic vaccination.  On an unknown date, the patient received an unknown dose of suspect INFLUENZA SPLIT TRITON INTRADERMAL THIOMERSAL FREE VACCINE (lot number: unknown and expiration date: unknown) via unknown route in unknown administration site for prophylactic vaccination.  On 19-Sep-2016, the patient who experienced general malaise (malaise), chills, fever (pyrexia), severe headache (headache), cough, sore throat (oropharyngeal pain), felt weak (asthenia), pain coming up the neck (neck pain), being down for 14 weeks/ miserable (depressed mood) and extreme fatigue (fatigue), same day after following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE and INFLUENZA SPLIT TRITON INTRADERMAL THIOMERSAL FREE VACCINE.  On 03-Oct-2016, the patient who experienced sore throat (oropharyngeal pain), 14 days after following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE and INFLUENZA SPLIT TRITON INTRADERMAL THIOMERSAL FREE VACCINE.  On an unknown date, the patient who felt weak (asthenia), (latency: unknown) after following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE and INFLUENZA SPLIT TRITON INTRADERMAL THIOMERSAL FREE VACCINE.  Relevant laboratory test results included: Thyroid function test - On an unknown date: [two complete sets of blood work including thyroid panel] and X-ray - On an unknown date: [On an unknown day, Chest X-ray (Cxr) was performed, but no result was provided].   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of events was resolved on an unknown date for the events except unknown for Neck pain, Feeling down and Fatigue.  Additional information regarding an unsolicited valid non-serious case from a physician and consumer/ non-health care professional via Medical Information (Reference number- 00481715).  Start date of the suspect, medical history, concomitant medications and outcome of the events were updated. List of documents held by sender: none.  Corresponding fields and narrative were updated.  Additional information regarding an unsolicited valid non-serious case from a physician and consumer/ non-health care professional via Medical Information (Reference number- 00481715).  New events neck pain, feeling down and fatigue was added, lower level term for the event cough was updated to coughing, start date for the event was updated to 19-Sep-2016 from 06-Oct-2016, suspect information was updated (dosing details), batch number was updated from UI620AB to V1620AB, new suspect IDFLU was updated.  Corresponding fields and narrative were updated.